Mohammad H Afzali1, Matthew Sunderland2, Maree Teesson2, Natacha Carragher3, Katherine Mills2, Tim Slade2. 1. NHMRC Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia. Electronic address: m.afzali@unsw.edu.au. 2. NHMRC Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia. 3. Office of Medical Education, Faulty of Medicine, UNSW, Sydney, Australia.
Abstract
BACKGROUND: The role of symptom overlap between major depressive disorder and posttraumatic stress disorder in comorbidity between two disorders is unclear. The current study applied network analysis to map the structure of symptom associations between these disorders. METHODS: Data comes from a sample of 909 Australian adults with a lifetime history of trauma and depressive symptoms. Data analysis consisted of the construction of two comorbidity networks of PTSD/MDD with and without overlapping symptoms, identification of the bridging symptoms, and computation of the centrality measures. RESULTS: The prominent bridging role of four overlapping symptoms (i.e., sleep problems, irritability, concentration problems, and loss of interest) and five non-overlapping symptoms (i.e., feeling sad, feelings of guilt, psychomotor retardation, foreshortened future, and experiencing flashbacks) is highlighted. LIMITATIONS: The current study uses DSM-IV criteria for PTSD and does not take into consideration significant changes made to PTSD criteria in DSM-5. Moreover, due to cross-sectional nature of the data, network estimates do not provide information on whether a symptom actively triggers other symptoms or whether a symptom mostly is triggered by other symptoms. CONCLUSION: The results support the role of dysphoria-related symptoms in PTSD/MDD comorbidity. Moreover, Identification of central symptoms and bridge symptoms will provide useful targets for interventions that seek to intervene early in the development of comorbidity.
BACKGROUND: The role of symptom overlap between major depressive disorder and posttraumatic stress disorder in comorbidity between two disorders is unclear. The current study applied network analysis to map the structure of symptom associations between these disorders. METHODS: Data comes from a sample of 909 Australian adults with a lifetime history of trauma and depressive symptoms. Data analysis consisted of the construction of two comorbidity networks of PTSD/MDD with and without overlapping symptoms, identification of the bridging symptoms, and computation of the centrality measures. RESULTS: The prominent bridging role of four overlapping symptoms (i.e., sleep problems, irritability, concentration problems, and loss of interest) and five non-overlapping symptoms (i.e., feeling sad, feelings of guilt, psychomotor retardation, foreshortened future, and experiencing flashbacks) is highlighted. LIMITATIONS: The current study uses DSM-IV criteria for PTSD and does not take into consideration significant changes made to PTSD criteria in DSM-5. Moreover, due to cross-sectional nature of the data, network estimates do not provide information on whether a symptom actively triggers other symptoms or whether a symptom mostly is triggered by other symptoms. CONCLUSION: The results support the role of dysphoria-related symptoms in PTSD/MDD comorbidity. Moreover, Identification of central symptoms and bridge symptoms will provide useful targets for interventions that seek to intervene early in the development of comorbidity.
Authors: Aimee James Karstens; Leah H Rubin; Stewart A Shankman; Olusola Ajilore; David J Libon; Anand Kumar; Melissa Lamar Journal: J Psychiatr Res Date: 2017-01-16 Impact factor: 4.791
Authors: Mohammad H Afzali; Matthew Sunderland; Philip J Batterham; Natacha Carragher; Alison Calear; Tim Slade Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2016-12-24 Impact factor: 4.328
Authors: Amit Lazarov; Benjamin Suarez-Jimenez; Ofir Levi; Daniel D L Coppersmith; Gadi Lubin; Daniel S Pine; Yair Bar-Haim; Rany Abend; Yuval Neria Journal: Psychol Med Date: 2019-08-27 Impact factor: 7.723
Authors: Katherine A Grisanzio; Andrea N Goldstein-Piekarski; Michelle Yuyun Wang; Abdullah P Rashed Ahmed; Zoe Samara; Leanne M Williams Journal: JAMA Psychiatry Date: 2018-02-01 Impact factor: 21.596